Satirapoj, Bancha, Supaporn Suebsiripong, and Saranyapong Runprapan. “Effects of Empagliflozin/Linagliptin on Oxidative Stress Markers in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Randomized, Open-Label, Controlled Trial”. Journal of the Nephrology Society of Thailand 31, no. 1 (March 18, 2025): 65–75. accessed December 7, 2025. https://he01.tci-thaijo.org/index.php/JNST/article/view/275823.